PatientsLikeMe has found more interest in its online tool for promoting clinical trials to members of its social network. The CRO outfit inVentiv Health and PatientsLikeMe have formed a partnership that could expand the use of services from both companies.
PatientsLikeMe wants to improve patient-reported outcomes in clinical trials by opening up to developers of disease assessment questionnaires. The platform--Open Research Exchange--allows firms to work with the patient community to assess ways of gathering the outcomes data payers increasingly want.
An analysis of online data found that only 7.4% of 650 clinical trials for diabetes treatments included patient-reported outcomes, which are supposed to shed light on patients' experiences on the meds.
Instem has bought a ticket to play a larger role in the market for early-stage clinical trials. The provider of IT solutions has acquired Logos Technologies, which provides electronic data-capture (EDC) software for pharma, biotech and CRO companies.
GlaxoSmithKline turned on a website that serves as a conduit for authorized researchers to tap clinical study data on certain GSK drugs, placing the pharma giant on the forefront of transparency in pharma and spurring skepticism about the process for releasing anonymous patient-level data from its vaults.
The life sciences industry is warming up to cloud computing, or so Medidata Solutions' first quarter financial results would seem to indicate.
Oracle and Accelrys, both of which are key players in the R&D software world, have trotted out updates on important products in their respective tech portfolios.
It can be hard to stand out in the congested eClinical sector. Developing a tool based on the buzz topics of analytics and social networking helps. Being linked to high-profile conference TEDMED is a boon too. Fortunately for clinical software firm ViS Research Institute, it ticks all these boxes.
Another clinical trial search engine rolled out this week with talk of making it easier for patients to find studies, and vice versa. But the website, MyClinicalTrialLocator, finds itself in an increasingly congested market filled with CROs, in-house Big Pharma platforms and niche players.
After a pair of deals to go private and merge with another company, BioClinica aims to expand its clinical trials software and services business in Asia without cutbacks--at least for now, The Philadelphia Inquirer reported. And the newly privatized company's chief executive expects to capitalize on pharma giants' race to develop new drugs to replace those fallen off patent.